Literature DB >> 21277546

Whole-brain radiotherapy in primary CNS lymphoma.

Andrés J M Ferreri, Lisa DeAngelis, Gerald Illerhaus, Brian P O'Neill, Michele Reni, Carole Soussain, Joachim Yahalom.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21277546     DOI： 10.1016/S1470-2045(11)70018-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.

Authors:  Christian Grommes; James L Rubenstein; Lisa M DeAngelis; Andres J M Ferreri; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

Review 2.  Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.

Authors:  Andrés José María Ferreri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Diagnosis and treatment of primary CNS lymphoma.

Authors:  Agnieszka Korfel; Uwe Schlegel
Journal:  Nat Rev Neurol       Date:  2013-05-14       Impact factor: 42.937

4.  Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.

Authors:  Patrick G Morris; Denise D Correa; Joachim Yahalom; Jeffrey J Raizer; David Schiff; Barbara Grant; Sean Grimm; Rose K Lai; Anne S Reiner; Kathy Panageas; Sasan Karimi; Richard Curry; Gaurav Shah; Lauren E Abrey; Lisa M DeAngelis; Antonio Omuro
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

5.  A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.

Authors:  Narayan Adhikari; Ahitagni Biswas; Ajay Gogia; Ranjit Kumar Sahoo; Ajay Garg; Ashima Nehra; Mehar Chand Sharma; Suman Bhasker; Manmohan Singh; Vishnubhatla Sreenivas; Rohan Chawla; Garima Joshi; Lalit Kumar; Subhash Chander
Journal:  J Neurooncol       Date:  2018-04-09       Impact factor: 4.130

6.  Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.

Authors:  Caroline Houillier; Carole Soussain; Hervé Ghesquières; Pierre Soubeyran; Olivier Chinot; Luc Taillandier; Thierry Lamy; Sylvain Choquet; Guido Ahle; Gandhi Damaj; Philippe Agapé; Cécile Moluçon-Chabrot; Alexandra Amiel; Vincent Delwail; Michel Fabbro; Fabrice Jardin; Adrien Chauchet; Marie-Pierre Moles-Moreau; Franck Morschhauser; Olivier Casasnovas; Rémy Gressin; Luc-Matthieu Fornecker; Julie Abraham; Jean-Pierre Marolleau; Adrian Tempescul; Chantal Campello; Philippe Colin; Jérôme Tamburini; Kamel Laribi; Caroline Serrier; Corinne Haioun; Safia Chebrek; Anna Schmitt; Marie Blonski; Roch Houot; Eileen Boyle; Jacques-Olivier Bay; Lucie Oberic; Emeline Tabouret; Agathe Waultier; Nadine Martin-Duverneuil; Valérie Touitou; Nathalie Cassoux; Aurélie Kas; Karima Mokhtari; Frederic Charlotte; Agusti Alentorn; Loïc Feuvret; Magali Le Garff-Tavernier; Myrto Costopoulos; Bertrand Mathon; Matthieu Peyre; Daniel Delgadillo; Hassen Douzane; Diane Genet; Bachir Aidaoui; Khê Hoang-Xuan; Emmanuel Gyan
Journal:  Neurology       Date:  2020-01-06       Impact factor: 9.910

7.  Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.

Authors:  Dong Won Baek; Hee Jeong Cho; Jae Heung Bae; Sang Kyun Sohn; Joon Ho Moon
Journal:  Blood Res       Date:  2020-06-30

8.  Clinical Features, Diagnosis, and Treatment of Primary Intraventricular Lymphoma: Insights From a Monocentric Case Series.

Authors:  Lidong Cheng; Hongtao Zhu; Jing Wang; Guanghui Wang; Xiaoyu Ma; Kai Zhao; Junwen Wang; Kai Shu
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

Review 9.  Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option.

Authors:  Michel Zimmermann; Christoph Oehler; Ulrich Mey; Pirus Ghadjar; Daniel Rudolf Zwahlen
Journal:  Radiat Oncol       Date:  2016-08-30       Impact factor: 3.481
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.